Home › Free Stock Grades › FRX.TO
Fennec Pharmaceuticals Inc. (FRX.TO) Stock Grade
FRX.TO · Healthcare
C+
Market Cap
$220.6M
P/E Ratio
—
Revenue Growth (YoY)
-6.1%
Net Margin
-21.8%
Return on Equity
—
Dividend Yield
None
About Fennec Pharmaceuticals Inc.'s fundamentals
Fennec Pharmaceuticals is a small-cap biotech company with a market capitalization of $220.6 million that reported a net loss in its latest annual statement, resulting in a negative net margin of -21.8%. The company experienced a year-over-year revenue decline of 6.1%, indicating contraction in its top line. As an unprofitable biotech firm, traditional valuation metrics like P/E ratio and return on equity are not applicable, and the company does not pay dividends.